两种不同卵母细胞玻璃化冷冻方法的比较:同一遗传背景和刺激方案下的前瞻性配对研究
该前瞻性配对研究在2014年7月至2016年1月纳入83名卵母细胞捐赠者,每位捐赠者至少提供12枚成熟卵母细胞,将同胞卵母细胞分别采用开放法和封闭法玻璃化冷冻。封闭法卵母细胞存活率高于开放法(94.5% vs 88.9%,P=0.002),但受精率低于开放法(57.1% vs 69.8%,P<0.001),两组妊娠结局和累计活产率无显著差异。
要点
- 封闭法卵母细胞存活率94.5%,开放法88.9%,封闭法更高(P=0.002)。
- 封闭法受精率57.1%,开放法69.8%,封闭法更低(P<0.001)。
- 两组生化、临床、持续妊娠率及活产率均无显著差异(P>0.05)。
核心结论
- 尽管存活率和受精率不同,封闭法与开放法卵母细胞玻璃化冷冻应提供相似的生殖结局直至累计活产率。
研究设计与样本
- 前瞻性队列研究,采用同胞卵母细胞配对设计,2014年7月至2016年1月在生育中心进行。
- 纳入83名卵母细胞捐赠者,每位取卵时至少提供12枚成熟卵母细胞(MII)。
- 每位捐赠者的6枚MII卵母细胞用开放法玻璃化冷冻并分配给一名接受者,另6枚MII卵母细胞用封闭法玻璃化冷冻并分配给另一名接受者。
- 所有病例采用ICSI,所有病例在Day 2-3进行胚胎移植。
主要发现
- 卵母细胞捐赠者平均年龄24.8岁(SD 4.7);接受者年龄(平均41.2岁,SD 4.7)和BMI(平均23.8 kg/m2,SD 4.0)在两组间相似。
- 封闭法卵母细胞存活率高于开放法(94.5% vs 88.9%,P=0.002)。
- 封闭法受精率低于开放法(57.1% vs 69.8%,P<0.001)。
- 两组新鲜移植胚胎数平均1.8枚(SD 0.4)。
- 生化妊娠率(封闭法45% vs 开放法50%)、临床妊娠率(40% vs 50%)、持续妊娠率(37.5% vs 42.5%)组间无显著差异(P>0.05),活产率亦无显著差异(37.5% vs 42.5%,P>0.05)。
关键数值与推荐
- 卵母细胞存活率:封闭法94.5% vs 开放法88.9%(P=0.002)。
- 受精率:封闭法57.1% vs 开放法69.8%(P<0.001)。
- 生化妊娠率:封闭法45% vs 开放法50%(P>0.05)。
- 临床妊娠率:封闭法40% vs 开放法50%(P>0.05)。
- 持续妊娠率:封闭法37.5% vs 开放法42.5%(P>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究参与者为卵母细胞捐赠者,即年轻健康女性,将结果外推至不孕症患者、肿瘤生育力保存患者及为延迟生育而冻卵的女性时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can two different methods for oocyte vitrification, one using an open tool and the other a closed tool, result in similar oocyte survival rates? SUMMARY ANSWER: The oocyte survival rate was found to be higher in the closed method. WHAT IS KNOWN ALREADY: Open vitrification is performed routinely in oocyte donation cycles. Closed oocyte vitrification may result in slower cooling rates and thus it is less used, even though it has been recommended in order to avoid the risk of cross-contamination between material from different patients. STUDY DESIGN, SIZE, DURATION: This is a prospective cohort study with sibling oocytes carried out in a fertility center between July 2014 and January 2016. The study included 83 oocyte donors each providing a minimum of 12 mature oocytes (metaphase II: MII) at oocyte retrieval. Oocyte survival rate and fertilization rate, as well as reproductive outcomes (biochemical, clinical, ongoing pregnancy and live birth rates) per embryo transfer and also cumulatively between the two methods were compared by Chi2 tests. PARTICIPANTS/MATERIALS, SETTING, METHODS: Donor oocytes were denuded and six MII oocytes from each donor were vitrified using an open method and later assigned to one recipient, while another six MII oocytes were vitrified using a closed method and assigned to a different recipient (paired analysis). ICSI was used in all cases and embryo transfer was performed on Day 2-3 in all cases. MAIN RESULTS AND THE ROLE OF CHANCE: Oocyte donors were 24.8 years old on average (SD 4.7). Recipient age (average 41.2 years, SD 4.7) and BMI (mean 23.8 kg/m2, SD 4.0) were similar between recipient groups. Oocytes vitrified using the closed method had higher survival rate (94.5% versus 88.9%, P = 0.002), but lower fertilization rate (57.1% versus 69.8%, P < 0.001) compared to the open method. The number of fresh embryos transferred in the two groups was 1.8 on average (SD 0.4). Biochemical (45% closed versus 50% open), clinical (40% versus 50%) and ongoing (37.5% versus 42.5%) pregnancy rates were not different between groups (P > 0.05) and neither were live birth rates (37.5% versus 42.5%, P > 0.05). Cumulative reproductive results (obtained after the transfer of all the embryos) were also similar between groups. LIMITATIONS, REASONS FOR CAUTION: The participants of this study were oocyte donors, i.e. young women in good health, and care should be exerted in extending our results to other populations such as infertility patients, oncofertility patients and women freezing oocytes to delay childbearing. WIDER IMPLICATIONS OF THE FINDINGS: Our results suggest that, in spite of different survival and fertilization rates, closed and open oocyte vitrification methods should offer similar reproductive outcomes up to cumulative live birth rates. STUDY FUNDING/COMPETING INTEREST(S): The authors report no conflict of interest. Vitrolife provided the media and the closed method tool needed for the study at no cost.
引用
- Pujol A, Zamora MJ, Obradors A, et al. Comparison of two different oocyte vitrification methods: a prospective, paired study on the same genetic background and stimulation protocol. Hum Reprod. 2019. PMID: 31116386. doi:10.1093/humrep/dez045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。